Immuneering Accounts Payable from 2010 to 2025

IMRX Stock  USD 1.69  0.05  2.87%   
Immuneering Corp Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 1.9 M in 2025. Accounts Payable is the amount Immuneering Corp owes to suppliers or vendors for products or services received but not yet paid for. It represents Immuneering Corp's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
M
Current Value
1.9 M
Quarterly Volatility
927.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immuneering Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immuneering Corp's main balance sheet or income statement drivers, such as Net Interest Income of 2.7 M, Interest Income of 1.3 M or Depreciation And Amortization of 425.1 K, as well as many indicators such as Price To Sales Ratio of 207, Dividend Yield of 0.0 or PTB Ratio of 0.0017. Immuneering financial statements analysis is a perfect complement when working with Immuneering Corp Valuation or Volatility modules.
  
Check out the analysis of Immuneering Corp Correlation against competitors.
For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.

Latest Immuneering Corp's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Immuneering Corp over the last few years. An accounting item on the balance sheet that represents Immuneering Corp obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Immuneering Corp are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Immuneering Corp's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immuneering Corp's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Immuneering Accounts Payable Regression Statistics

Arithmetic Mean934,674
Geometric Mean596,330
Coefficient Of Variation99.24
Mean Deviation799,658
Median294,948
Standard Deviation927,580
Sample Variance860.4B
Range2.9M
R-Value0.79
Mean Square Error341.4B
R-Squared0.63
Significance0.0002
Slope154,605
Total Sum of Squares12.9T

Immuneering Accounts Payable History

20251.9 M
2024M
20232.1 M
20223.2 M
20211.4 M
20201.5 M

About Immuneering Corp Financial Statements

Immuneering Corp investors use historical fundamental indicators, such as Immuneering Corp's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immuneering Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts PayableM1.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immuneering Stock Analysis

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.